Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01152021 · ClinicalTrials.gov registry record · Phase 3
Comparing Safety and Efficacy of Dexmedetomidine and Propofol
A Phase 3 study, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- Phase 3
- Development phase
- 15
- Enrollment target
NCT01152021 is a Phase 3 study that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 15 participants.
The verdict
NCT01152021, a Phase 3 study, was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a prospective, open label randomized study. The purpose of this study is to compare propofol with dexmedetomidine for pediatric monitored anesthesia care for MRI, specifically identifying important patient demographics and looking at important outcomes including adverse events.
Interventions
- DRUG Dexmedetomidine
- DRUG Propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01152021
The ClinicalTrials.gov registry entry for NCT01152021 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexmedetomidine is the first listed.
NCT01152021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01152021 about?
NCT01152021 is a clinical study titled "Comparing Safety and Efficacy of Dexmedetomidine and Propofol". This is a prospective, open label randomized study. The purpose of this study is to compare propofol with dexmedetomidine for pediatric monitored anesthesia care for MRI, specifically identifying important patient demographics and looking at important outcomes including adverse events.
What is the current status of trial NCT01152021?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 15 participants. The study started on 2011-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01152021?
The interventions under investigation include: Dexmedetomidine (DRUG), Propofol (DRUG).
Who is sponsoring clinical trial NCT01152021?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.